Low Dose Rapamycin Treatment Increases the Ability of Ex Vivo Expanded Human Regulatory T Cells To Inhibit Transplant Arteriosclerosis In Vivo

被引：0
|
作者：
Nadig, S. N. [1 ]
Hester, J. [1 ]
Schiopu, A. [1 ]
Wood, K. J. [1 ]
机构：
[1] Univ Oxford, John Radcliffe Hosp, Transplant Res Immunol Grp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
134
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Low-Dose Rapamycin Treatment Increases the Ability of Human Regulatory T Cells to Inhibit Transplant Arteriosclerosis In Vivo
    Hester, J.
    Schiopu, A.
    Nadig, S. N.
    Wood, K. J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (08) : 2008 - 2016
  • [2] In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells
    Satish N Nadig
    Joanna Więckiewicz
    Douglas C Wu
    Gregor Warnecke
    Wei Zhang
    Shiqiao Luo
    Alexandru Schiopu
    David P Taggart
    Kathryn J Wood
    Nature Medicine, 2010, 16 : 809 - 813
  • [3] In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
    Nadig, Satish N.
    Wieckiewicz, Joanna
    Wu, Douglas C.
    Warnecke, Gregor
    Zhang, Wei
    Luo, Shiqiao
    Schiopu, Alexandru
    Taggart, David P.
    Wood, Kathryn J.
    NATURE MEDICINE, 2010, 16 (07) : 809 - U112
  • [4] Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model
    Nadig, S. N.
    Wiekiewicz, J.
    Wu, D. C.
    Warnecke, G.
    Zhang, W.
    Luo, S.
    Taggart, D.
    Wood, K. J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02) : S179 - S179
  • [5] The Effect of Ex Vivo Preservation and Regulatory T Cells on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model
    Knoefel, A.
    Siemeni, T.
    Ius, F.
    Sommer, W.
    Salman, J.
    Tudorache, I.
    Haverich, A.
    Falk, C.
    Warnecke, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 718 - 719
  • [6] Regulatory T Cells and the Effect of Ex Vivo Preservation on the Development of Transplant Arteriosclerosis in a Humanized Mouse Model
    Knoefel, A.
    Siemeni, T.
    Ius, F.
    Avsar, M.
    Hacker, K.
    Salman, J.
    Haverich, A.
    Falk, C.
    Warnecke, G.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04) : S344 - S344
  • [7] Impact of immunosuppressive regimen on ex vivo expanded human regulatory T-cells
    Scotta, C.
    Fanelli, G.
    Hoong, J.
    Romano, M.
    Sukthankar, M.
    Guggino, G.
    Fazekasova, H.
    Kulachelvy, R.
    Becker, P.
    Afzali, B.
    Lechler, R.
    Lombardi, G.
    IMMUNOLOGY, 2014, 143 : 144 - 144
  • [8] Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells
    Scotta, Cristiano
    Fanelli, Giorgia
    Hoong, Sec Julie
    Romano, Marco
    Lamperti, Estefania Nova
    Sukthankar, Mitalee
    Guggino, Giuliana
    Fazekasova, Henrieta
    Ratnasothy, Kulachelvy
    Becker, Pablo D.
    Afzali, Behdad
    Lechler, Robert I.
    Lombardi, Giovanna
    HAEMATOLOGICA, 2016, 101 (01) : 91 - 100
  • [9] Rapamycin Enhances the Suppressive Capacity of Ex Vivo Expanded Regulatory T Cells (Tregs) Isolated From Pediatric Thymus
    Dijke, E.
    Hoeppli, R.
    Ellis, T.
    Pearcey, J.
    Larsen, I.
    Rebeyka, I.
    Ross, D.
    Levings, M.
    West, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04) : S147 - S148
  • [10] Migratory properties of ex vivo expanded regulatory T cells: Influence of all-trans retinoic acid and rapamycin
    Beermann, J. L.
    Thiesler, C. T.
    Dringenberg, U.
    Alter, C.
    Kuhs, S.
    Velaga, S.
    Ukena, S. N.
    Franzke, A.
    TRANSPLANT IMMUNOLOGY, 2017, 45 : 29 - 34
12345